Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex Pharmaceuticals

500.80
-8.7050-1.71%
Volume:763.77K
Turnover:383.56M
Market Cap:128.74B
PE:-240.77
High:507.75
Open:507.00
Low:498.25
Close:509.50
Loading ...

Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom -- Barrons.com

Dow Jones
·
22 Apr

BNP Paribas Exane Initiates Coverage on Vertex With Outperform Rating, $54 Price Target

MT Newswires Live
·
22 Apr

Vertex Pharmaceuticals Coverage Assumed by Cantor Fitzgerald at Overweight

Dow Jones
·
22 Apr

Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
22 Apr

Vertex Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald

TIPRANKS
·
22 Apr

Vertex Pharmaceuticals (NasdaqGS:VRTX) Faces UK Patent Lawsuit Over Groundbreaking CASGEVY Therapy

Simply Wall St.
·
22 Apr

ST Engineering group COO Ravinder Singh to retire; Vertex Holdings’ managing director Mervyn Tan to take his place

businesstimes
·
18 Apr

BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $557 From $545

MT Newswires Live
·
18 Apr

Vertex Pharmaceuticals Inc : Bmo Raises Target Price to $557 From $520

THOMSON REUTERS
·
17 Apr

Vertex Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
17 Apr

Vertex Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
17 Apr

Vertex price target lowered to $55 from $60 at Morgan Stanley

TIPRANKS
·
16 Apr

Vertex Minerals Highlights Gold Mining Prospects at Noosa Conference

TIPRANKS
·
15 Apr

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
15 Apr

Vertex to Announce First Quarter 2025 Financial Results on Wednesday, May 7, 2025

GlobeNewswire
·
15 Apr

Vertex Is Maintained at Buy by DA Davidson

Dow Jones
·
15 Apr

Vertex price target lowered to $50 from $55 at DA Davidson

TIPRANKS
·
14 Apr

Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades

Motley Fool
·
12 Apr

Pharma Tariffs Are Coming. Investors Underestimate the Risk. -- Barrons.com

Dow Jones
·
12 Apr

Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

Business Wire
·
11 Apr